| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Central Arkansas Veterans Health Care System and Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
Adeno-associated virus (AAV) is a nonpathogenic, single-stranded DNA virus belonging to the parvoviridae family. Onco-suppressive properties of AAV against adenovirus, a DNA tumor virus, have been well documented. Rep78, a major regulatory protein of AAV, is believed to be responsible for its antioncogenic properties. Most DNA tumor viruses disturb the cell cycle pathways by essentially abrogating the functions of p53. Here we present evidence that AAV acts as an antiproliferative agent against adenovirus by protecting the adenoviral-mediated degradation of p53 as confirmed by both Western blot analysis and immunoprecipitation analysis with anti-p53 antibody. Coimmunoprecipitation experiments revealed that the AAV Rep78 is physically bound to p53 in vivo. Furthermore, the binding of purified p53 to the AAV Rep78 affinity column confirms their interaction. These results document for the first time that the antiproliferative effects of AAV against adenovirus are mediated, at least in part, by the interaction of AAV Rep78 with p53.
This article has been cited by other articles:
![]() |
K. Nash, W. Chen, M. Salganik, and N. Muzyczka Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein J. Virol., January 1, 2009; 83(1): 454 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Alam, E. Sen, H. Brashear, and C. Meyers Adeno-Associated Virus Type 2 Increases Proteosome-Dependent Degradation of p21WAF1 in a Human Papillomavirus Type 31b-Positive Cervical Carcinoma Line. J. Virol., May 1, 2006; 80(10): 4927 - 4939. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berthet, K. Raj, P. Saudan, and P. Beard How adeno-associated virus Rep78 protein arrests cells completely in S phase PNAS, September 20, 2005; 102(38): 13634 - 13639. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Batchu, M. A. Shammas, J. Y. Wang, J. Freeman, N. Rosen, and N. C. Munshi Adeno-associated Virus Protects the Retinoblastoma Family of Proteins from Adenoviral-induced Functional Inactivation Cancer Res., May 1, 2002; 62(10): 2982 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Weger, E. Hammer, and R. Heilbronn Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression J. Gen. Virol., March 1, 2002; 83(3): 511 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmidt, J. A. Chiorini, S. Afione, and R. Kotin Adeno-Associated Virus Type 2 Rep78 Inhibition of PKA and PRKX: Fine Mapping and Analysis of Mechanism J. Virol., February 1, 2002; 76(3): 1033 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmidt, S. Afione, and R. M. Kotin Adeno-Associated Virus Type 2 Rep78 Induces Apoptosis through Caspase Activation Independently of p53 J. Virol., October 15, 2000; 74(20): 9441 - 9450. [Abstract] [Full Text] |
||||
![]() |
P. Ogston, K. Raj, and P. Beard Productive Replication of Adeno-Associated Virus Can Occur in Human Papillomavirus Type 16 (HPV-16) Episome-Containing Keratinocytes and Is Augmented by the HPV-16 E2 Protein J. Virol., April 15, 2000; 74(8): 3494 - 3504. [Abstract] [Full Text] |
||||
![]() |
R. B. Batchu, M. A. Shammas, J. Y. Wang, and N. C. Munshi Dual Level Inhibition of E2F-1 Activity by Adeno-associated Virus Rep78 J. Biol. Chem., June 22, 2001; 276(26): 24315 - 24322. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |